NASDAQ:GEHC - Nasdaq - US36266G1076 - Common Stock - Currency: USD
GE HEALTHCARE TECHNOLOGY
NASDAQ:GEHC (1/30/2025, 1:47:04 PM)
89.595
+1.75 (+1.99%)
The current stock price of GEHC is 89.595 USD. In the past month the price increased by 10.49%. In the past year, price increased by 18.86%.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
/PRNewswire/ -- USA News Group News Commentary – As the new administration starts to make its mark in the United States, President Trump recently announced a...
See which three big-name U.S. stocks have announced new buyback programs as the first earnings season of 2025 kicks into gear.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.63 | 223.81B | ||
ISRG | INTUITIVE SURGICAL INC | 79.53 | 207.64B | ||
BSX | BOSTON SCIENTIFIC CORP | 44.01 | 153.09B | ||
SYK | STRYKER CORP | 32.31 | 150.14B | ||
MDT | MEDTRONIC PLC | 17.66 | 118.92B | ||
BDX | BECTON DICKINSON AND CO | 18.98 | 72.42B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.56 | 43.39B | ||
RMD | RESMED INC | 31.22 | 38.00B | ||
IDXX | IDEXX LABORATORIES INC | 39.03 | 35.00B | ||
DXCM | DEXCOM INC | 51.72 | 34.35B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 20.93 | 26.37B | ||
ZBH | ZIMMER BIOMET HOLDINGS INC | 14.16 | 22.25B |
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 51,000 full-time employees. The company went IPO on 2022-12-15. The firm provides integrated solutions, services, and data analytics. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. The segment also includes the clinical artificial intelligence (AI) software business. Its PCS segment portfolio consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment consists of two business lines: contrast media and molecular imaging.
GE HEALTHCARE TECHNOLOGY
500 West Monroe Street
Chicago ILLINOIS US
Employees: 51000
Company Website: https://www.gehealthcare.com
Investor Relations: https://investor.gehealthcare.com/
Phone: 18337351139
The current stock price of GEHC is 89.595 USD.
The exchange symbol of GE HEALTHCARE TECHNOLOGY is GEHC and it is listed on the Nasdaq exchange.
GEHC stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for GEHC, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of GEHC.
GEHC has a dividend yield of 0.16%. The yearly dividend amount is currently 0.09.
GEHC will report earnings on 2025-02-13, after the market close.
The PE ratio for GEHC is 21.23. This is based on the reported non-GAAP earnings per share of 4.22 and the current share price of 89.595 USD.
The outstanding short interest for GEHC is 2.74% of its float.
ChartMill assigns a technical rating of 8 / 10 to GEHC. When comparing the yearly performance of all stocks, GEHC turns out to be only a medium performer in the overall market: it outperformed 67.58% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to GEHC. GEHC has an excellent profitability rating, but there are concerns on its financial health.
Over the last trailing twelve months GEHC reported a non-GAAP Earnings per Share(EPS) of 4.22. The EPS increased by 3.69% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 8.56% | ||
ROA | 4.95% | ||
ROE | 20.14% | ||
Debt/Equity | 1.12 |
ChartMill assigns a Buy % Consensus number of 78% to GEHC. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 11.13% and a revenue growth 1.37% for GEHC